This is consistent with previous research indicating that pterocarpan derivatives inhibit oncogenic kinases, including AKT and GSK3B, resulting in cell-cycle arrest and death in breast, prostate, and liver malignancies [19,20,21]. This evidence concerns the gene AKT1 and medical procedure.